| 产品编号 | MAV109 |
|---|---|
| 产品名称 | Mouse anti-COVID-19/SARS-CoV-2 Monoclonal Antibody (Neutralizing) |
| 抗体亚型 | IgG1 |
| 克隆号 | 3F6 |
| 产品别名 | Native SARS-CoV-2 Neutralizing antibody, 2019-nCoV |
| 规格 | 100ul, 500ul |
| 规格与价格 | 100ul/￥2,300; 500ul/￥6,500 |
| 物种 | COVID-19 |
| 宿主 | Mouse |
| 免疫原 | Inactivated Native Virus |
| 产品应用 | ELISA, Neutralization(>1:1024) |
| 生物活性 | N.A |
| 缓冲体系 | 0.01M PBS, pH 7.4 |
| 产品背景 | The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; previously provisionally named 2019 novel coronavirus or 2019-nCoV) disease (COVID-19) in China at the end of 2019 has caused a large global outbreak and is a major public health issue. As of 11 February 2020, data from the World Health Organization (WHO) have shown that more than 43 000 confirmed cases have been identified in 28 countries/regions, with >99% of cases being detected in China. On 30 January 2020, the WHO declared COVID-19 as the sixth public health emergency of international concern. SARS-CoV-2 is closely related to two bat-derived severe acute respiratory syndrome-like coronaviruses, bat-SL-CoVZC45 and bat-SL-CoVZXC21. It is spread by human-to-human transmission via droplets or direct contact, and infection has been estimated to have mean incubation period of 6.4 days and a basic reproduction number of 2.24-3.58. Among patients with pneumonia caused by SARS-CoV-2 (novel coronavirus pneumonia or Wuhan pneumonia), fever was the most common symptom, followed by cough. Bilateral lung involvement with ground-glass opacity was the most common finding from computed tomography images of the chest. The one case of SARS-CoV-2 pneumonia in the USA is responding well to remdesivir, which is now undergoing a clinical trial in China. Currently, controlling infection to prevent the spread of SARS-CoV-2 is the primary intervention being used. However, public health authorities should keep monitoring the situation closely, as the more we can learn about this novel virus and its associated outbreak, the better we can respond. |
| 保存条件 | This product can be stored at 2℃-8℃ for one month. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Avoid repeated freeze-thaw cycles. |
| 备注 | This product is used for research use only. Not for human or diagnostic use. |
鼠 anti-COVID-19/SARS-CoV-2 单克隆抗体 (Neutralizing)
人气:82 销量:0 评价:0
| 单价 | ￥2300.00 |
| 库存 | 1000件 |
| 品牌 | 卡梅德生物 |
- 商品详情
- 评价详情(0)
- 交易记录(0)
联系方式
公司:卡梅德生物科技（天津）有限公司
状态:离线 发送信件 在线交谈
姓名:张(女士)
职位:项目经理
电话:13116038708
手机:13116038708
地区:天津
地址:天津市武清开发区畅源道国际企业社区 A5 号楼四层
邮编:301700
邮件:info@kmdbioscience.com
QQ:2984911078
微信:13116038708
状态:离线 发送信件 在线交谈
姓名:张(女士)
职位:项目经理
电话:13116038708
手机:13116038708
地区:天津
地址:天津市武清开发区畅源道国际企业社区 A5 号楼四层
邮编:301700
邮件:info@kmdbioscience.com
QQ:2984911078
微信:13116038708